4.6 Article

Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial

Tom Holvoet et al.

Summary: Fecal microbiota transplantation (FMT) therapy has shown promising efficacy in treating patients with treatment-resistant Irritable Bowel Syndrome (IBS), particularly in relieving predominant bloating symptoms. The treatment response was associated with higher microbiome diversity in stool samples before FMT administration, suggesting a potential biomarker for patient selection.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome

Magdy El-Salhy et al.

Summary: This study found that FMT can increase the fecal SCFA levels in IBS patients. The increase in butyric acid is negatively correlated with symptoms in IBS patients, suggesting that SCFAs may play a role in the pathophysiology of IBS.

NEUROGASTROENTEROLOGY AND MOTILITY (2021)

Article Biotechnology & Applied Microbiology

Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules

Qingqing Guo et al.

Summary: FMT therapy shows potential for alleviating clinical symptoms and restoring intestinal micro-ecology in IBS-D patients with comorbid anxiety and depression.

BIOENGINEERED (2021)

Article Gastroenterology & Hepatology

The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study

Anna Maria Alcasid Madsen et al.

Summary: This study found no clinically beneficial effect of faecal microbiota transplantation on abdominal pain, stool frequency, or stool form in patients with irritable bowel syndrome. Further research is needed due to conflicting results in the current literature, and future studies are recommended to include daily symptom diaries both before and after treatment intervention.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms

Patrick Denis Browne et al.

Summary: FMT treatment induces significant long-term changes in the gut microbiome of IBS patients, including the engraftment of anaerobic bacteria and increased microbial diversity, but these changes do not correlate with clinical improvement. The relationship between the microbiome and the etiology of IBS remains unresolved.

GUT MICROBES (2021)

Review Gastroenterology & Hepatology

Global burden of irritable bowel syndrome: trends, predictions and risk factors

Christopher J. Black et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Medicine, General & Internal

Functional Gastrointestinal Disorders 2 Irritable bowel syndrome

Alexander C. Ford et al.

LANCET (2020)

Review Gastroenterology & Hepatology

Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing: A Systematic Review

Ruqiao Duan et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome

Gianluca Ianiro et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Review Gastroenterology & Hepatology

Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review

Rapat Pittayanon et al.

GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis

Kanchana Myneedu et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2019)

Article Gastroenterology & Hepatology

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Olga C. Aroniadis et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)

Editorial Material Gastroenterology & Hepatology

Functional Bowel Disorders

John W. Wiley et al.

GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Persisting changes of intestinal microbiota after bowel lavage and colonoscopy

Lorenzo Drago et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)

Editorial Material Gastroenterology & Hepatology

Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction INTRODUCTION

Douglas A. Drossman et al.

GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Bowel Disorders

Brian E. Lacy et al.

GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Effects of bowel cleansing on the intestinal microbiota

Jonna Jalanka et al.

Article Health Care Sciences & Services

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Xiang Wan et al.

BMC MEDICAL RESEARCH METHODOLOGY (2014)

Article Health Care Sciences & Services

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

Gordon Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)